Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • carole_smadja
    Junior Member
    • Oct 2010
    • 5

    #1

    Agilent SureSelect pre-capture multiplexing: which service provider ?

    Dear All,

    I plan a targeted resequencing experiment which would only be feasible if I can consider pre-capture multiplexing. I have already used in the past such application, but with a public facility which might not offer anymore this service. Would anyone know a service provider (SureSelect custon capture and HiSeq sequencing) which would offer pre-capture multiplexing services?

    THank you very much in advance to anyone with some information.

    Best wishes,
    Carole
  • Sri.rang
    Junior Member
    • Jan 2012
    • 2

    #2
    Hi Carole,

    Are you still looking for the same service?

    Regards,
    Sri

    Comment

    • kwaraska
      Senior Member
      • Nov 2008
      • 131

      #3
      Located in Boston

      I work at the Biopolymers Facility in Boston and we offer the Sure Select XT2 as a service.

      Please visit our website for further information

      The Biopolymers Facility at Harvard Medical School provides molecular biology services to the research community.

      Comment

      • Exeplex
        Member
        • Jun 2009
        • 10

        #4
        Originally posted by kwaraska View Post
        I work at the Biopolymers Facility in Boston and we offer the Sure Select XT2 as a service.

        Please visit our website for further information

        www.genome.med.harvard.edu
        ...though presumably this will depend on the total target size for your library - XT2 format baits libraries are currently only available from Agilent for targets >500 kb total (which is rather odd logic - it's at the smaller scales that you really need to mutlplex in order to get cost-effectiveness!).

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...